Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 18,160 | 21,578 | 19,362 | 24,935 | 23,545 |
| Cost of Goods | 14,968 | 12,716 | 12,066 | 15,441 | 15,318 |
| Gross Profit | 3,192 | 8,862 | 7,296 | 9,494 | 8,227 |
| Operating Expenses | 28,830 | 31,323 | 31,311 | 30,464 | 30,114 |
| Operating Income | -24,670 | -21,745 | -23,949 | -20,529 | -21,569 |
| Interest Expense | 616 | 598 | 581 | 624 | 633 |
| Other Income | 242 | -197 | 351 | 391 | 181 |
| Pre-tax Income | -25,044 | -22,540 | -24,179 | -20,762 | -22,021 |
| Net Income Continuous | -25,044 | -22,540 | -24,179 | -20,762 | -22,021 |
| Net Income | $-25,044 | $-22,540 | $-24,179 | $-20,762 | $-22,021 |
| EPS Basic Total Ops | -0.19 | -0.17 | -0.20 | -0.16 | -0.19 |
| EPS Basic Continuous Ops | -0.19 | -0.17 | -0.20 | -0.16 | -0.19 |
| EPS Diluted Total Ops | -0.19 | -0.17 | -0.20 | -0.16 | -0.19 |
| EPS Diluted Continuous Ops | -0.19 | -0.17 | -0.20 | -0.16 | -0.19 |
| EBITDA(a) | $-22,786 | $-19,843 | $-21,948 | $-18,479 | $-19,497 |